Type 1 Diabetes TrialNet: Clinical Centers (U01)

The summary for the Type 1 Diabetes TrialNet: Clinical Centers (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Type 1 Diabetes TrialNet: Clinical Centers (U01)
	CFDA Number:	93.213
	CFDA Description:	Research and Training in Complementary and Alternative Medicine
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Food and Nutrition Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-DK-08-011
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 29, 2008
	Creation Date:	Dec 24, 2008
	Original Closing Date for Applications:	Mar 10, 2009
	Current Closing Date for Applications:	Mar 10, 2009
	Archive Date:	Apr 10, 2009
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$5,400,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) .
Grant Description: Purpose. This FOA is being issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Center for Complementary and Alternative Medicine (NCCAM) to solicit applications to support clinical centers which will participate in studies aimed at preventing or delaying the onset or progression of type 1 diabetes (T1D) as part of the TrialNet clinical research network. TrialNet is working to achieve its goals through improving understanding of the natural history of the disease, screening and identifying persons at risk, and conducting clinical trials to evaluate promising new therapies that interdict the disease process. Most importantly, TrialNet evaluates new therapies, especially immunotherapies, in individuals (including children) who do not yet have clinical disease. To support the goal of prevention, TrialNet also performs studies that generate safety and efficacy information in individuals with newly-diagnosed diabetes. TrialNet tests interventions in patients with recent onset T1D to decrease b-cell destruction and/or enhance b-cell survival or regeneration in persons with T1D and residual b-cell function. In addition, TrialNet also evaluates methodologies to enhance the conduct of its clinical trials, which include tests of outcome assessment methodology, the evaluation of surrogate markers, and mechanistic studies (studies to understand underlying pathophysiology) laying the foundation for future clinical trials.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-dk-08-011.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Limited Competition: Strengthening Behavioral and Social Science in Medical School Education (R25); • Academic Career Award (Parent K07); • Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevent...; • Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevent...; • The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01); • Probiotics for Pediatric Illnesses; • CAM PRACTITIONER RESEARCH EDUCATION PROJECT GRANT PARTNERSHIP; • Complementary and Alternative Medicine Career Transition Award (K22); • Centers of Excellence for Research on Complementary and Alternative Medicine (CERC) [P01]; • Collaborative CAM Research Development Capability Enhancement Grant at Minority-Serving Institutions...